Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib with letrozole and goserelin in premenopausal ER+/HER2- breast cancer
NCT03628066Phase 2Completed
- Sponsor
- NSABP Foundation
- Start
- Oct 2018
- Primary completion
- Nov 2020
- Countries
- 2
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by NSABP Foundation. Started Oct 2018; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03628066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03628066.